Commerce Talks with Alexander Graf artwork

#121 – Applying e-commerce to health and well-being – Adam Docrat, Aster Pharmacy

Commerce Talks with Alexander Graf · with Adam Docrat · August 4, 2023 · 31 min

Summary

Adam Docrat, Head of IT at Aster Pharmacy, reveals how this pharmaceutical giant is leveraging e-commerce to expand into the health and well-being sectors. This episode offers key insights into the digital transformation of healthcare retail and the future of medicine delivery, crucial for any e-commerce operator looking at new market opportunities.

Key takeaways

Themes

digital transformatione-commerce expansionhealth and wellness marketpharmaceuticals

Topics covered

e-commerce in pharmaceuticalshealth and wellbeing sector expansionit strategy in healthcare retailmarket disruption in pharmacymedicine delivery e-commerce

Episode description

At Seamless Middle East, we spoke with Adam Docrat, Head of IT at Aster Pharmacy and Aster Retail. Aster is a hugely significant player in the pharmaceutical market in the Middle East, and it is now setting its sights on expansion into the health and well-being sectors. Adam discusses how they are approaching that sector while also explaining the world of pharmaceuticals and the future of medicine delivery and revealing how Aster uses e-commerce.

Frequently asked about this episode

What does this episode say about digital transformation?
Consider strategic expansion into related health and wellness sectors if you're in pharmaceuticals or a related e-commerce vertical.
What does this episode say about e-commerce expansion?
Implement robust e-commerce strategies for medicine delivery, focusing on user experience and efficiency.
What does this episode say about health and wellness market?
Explore how a large, established player like Aster Pharmacy uses e-commerce to maintain market relevance and drive growth.
What does this episode say about pharmaceuticals?
Identify potential technological and logistical challenges when integrating e-commerce into a traditional pharmaceutical business model.

Listen